跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
SEFFALAIR SPIROMAX 12.75 microgramos/202 microgramos POLVO PARA INHALACION
Approved
STANDARD
SEFFALAIR SPIROMAX 12.75 microgramos/202 microgramos POLVO PARA INHALACION
Teva B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 25, 2021
Approval ID
8f8c4802bb0218ad
Company
Teva B.V.
Type
Standard
Approval Details
Approval Id
8f8c4802bb0218ad
Drug Cima Aemps Name
SEFFALAIR SPIROMAX 12.75 microgramos/202 microgramos POLVO PARA INHALACION
Register Number
1211533003
Holder Company Name
Teva B.V.
Marketing Company Name
Teva Pharma S.L.U.
Holder Company Detail Path
/organization/teva-pharma-b-v
Authorization Date
2021-05-25
Dosage Form
POLVO PARA INHALACIÓN
Dose
12,75 microgramos/202 microgramos
Route Of Administration
VÍA INHALATORIA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Teva B.V.
Company Detail Path
/organization/teva-pharma-b-v
Company Information
Pharmaceutical Company Name
Teva Pharma B.V.
Country Name
Netherlands
City Name
haarlem,noord-holland,country_nl
Address
Swensweg 5
Website
http://www.tevapharm.com
Active Ingredients
SALMETEROL XINAFOATO
18,52 µg
FLUTICASONA PROPIONATO
202 µg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 25, 2021
Approval ID
8f8c4802bb0218ad
Type
Standard
Back to CIMA-AEMPS Approvals
SEFFALAIR SPIROMAX 12.75 microgramos/202 microgramos POLVO PARA INHALACION - CIMA-AEMPS Drug Approval Details
